Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) announced results for the fourth quarter and year ended December 31, 2009.
* Cubist acquired Calixa Therapeutics Inc. in December
* Operating income grew 52% over 2008
* Total net revenues for 2009 increased 30% over 2008

Related posts

Biomet Announces Financial [...]

Continue reading " Cubist Pharmaceuticals Announces Full Year 2009 Total Net Revenues of $562.1 Million "

Biomet, Inc. announced financial results for its second fiscal quarter ended November 30, 2009.
* Net sales increased 8% (5% constant currency) to $696 million worldwide and increased 8% in the U.S.
* Reconstructive sales, excluding dental, increased 12% (9% constant currency) worldwide, with 10% U.S. growth
[...]

Continue reading " Biomet Announces Financial Results for Second Quarter of Fiscal Year 2010 "

Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative microsurgical instruments for ophthalmic and neurosurgical applications, announced its results for the first quarter ended October 31, 2009. The Company reported first quarter 2010 sales of $12.1 million and net income of $542,000.

Related posts

Cubist Pharmaceuticals Announces Full Year 2009 [...]

Continue reading " Synergetics Announces First Quarter Results "

Angeion Corporation (NASDAQ: ANGN) reported results for its fiscal fourth quarter ended October 31, 2009.
Highlights
* Fourth quarter revenue of $6.6 million was sequentially up from third quarter
* Cash increased to $11.2 million, up $2.2 million from prior year-end
* Gross margin for the year [...]

Continue reading " Angeion Corporation Reports Fiscal 2009 Fourth-Quarter & Year-End Results "

Del Global Technologies Corp. (OTCBB: DGTC) (“Del Global” or “the Company”) announced financial results for its fiscal 2010 first quarter.
Highlights
* FY 2010 first quarter sales from continuing operations were $11.6 million reflecting soft customer demand
* FY 2010 first quarter loss from continuing operations was $0.4 million, or [...]

Continue reading " Del Global Technologies Reports Fiscal 2010 First Quarter Financial Results "

Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) reported results for the quarter ended October 31, 2009.
For the three months ended October 31, 2009, the Company reported net sales of $40.9 million, an increase of 63% from $25.1 million for the same period last year.

Related posts

Cubist Pharmaceuticals Announces Full Year 2009 Total Net Revenues of $562.1 Million [...]

Continue reading " Hi-Tech Pharmacal Reports Sales and Earnings for the Second Fiscal Quarter Ended October 31, 2009 "

Sirona (Nasdaq: SIRO), the dental technology leader, announced its financial results for the quarter and fiscal year ended September 30, 2009.
Fourth Quarter Fiscal 2009 vs. Fourth Quarter Fiscal 2008 Financial Results
Revenue was $188.2 million, an increase of $7.6 million or 4.2% (up 8.4% on a constant currency basis), with growth rates for the Company’s business [...]

Continue reading " Sirona Reports Fiscal 2009 Fourth Quarter and Full Year 2009 Results "

Retractable Technologies, Inc. (the “Company”) (AMEX: RVP), a leading maker of safety needle medical devices, reported revenues of $10.8 million for the three months ended September 30, 2009, an increase of 19.5% over the same period in 2008. The increase in total revenues from the year-ago quarter was partially due to the sales generated as [...]

Continue reading " Retractable Technologies, Inc. Has 3Q 2009 Revenues Increase 19.5 Percent Over 3Q 2008 "

Zynex, Inc. (OTCBB:ZYXI), a provider of pain management systems and electrotherapy products for medical patients with functional disability, reports its financial results for the third quarter of 2009. Revenue increased 113% to $4,690,715 and net income increased to $458,640 for the quarter.

Related posts

AVANIR Pharmaceuticals Announces Fiscal 2010 First Quarter Financial Results (0)
Medical Properties Trust, Inc. [...]

Continue reading " Zynex Reports Revenue and Profit in Third Quarter, 2009 "

ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and software solutions, announced that fiscal 2009 revenues were $385.2 million, compared to fiscal 2008 revenues of $398.0 million, a decline of 3%. Revenue results reflected a negative foreign exchange impact of nearly $12 million compared to fiscal 2008. The results include approximately $6.9 million [...]

Continue reading " ZOLL Medical Corporation Announces Annual Results "